Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

News and Press Releases

Read Veristat news and press releases to learn about our CRO service growth, geographic expansion in Europe and Asia, biotechnology preferred partnerships and small CRO acquisitions.

Posts about

Clinical Trials

Veristat congratulates Awakn - UK State Funding to Identify Optimal Pathway to Market In UK & US

Veristat congratulates Awakn for being awarded UK State Funding to Identify Optimal Pathway to...

Veristat Congratulates Origin Biosciences for FDA Approval

Veristat Congratulates Origin Biosciences for FDA Approval of Nulibry during the Week of Rare...

Veristat Launches Business Operations in Spain and Names Dr. Montserrat Barceló to Vice President, Europe

Leading the Organic and Acquisition Growth of Veristat Operations Throughout Europe

Veristat Named a Top Patient Recruitment Company by PharmaTech Outlook

Delivering A Patient-Centric Approach to Recruitment and Retention for Clinical Trials

...

Veristat Announces Global Cell and Gene Therapy Center of Excellence

Accelerating cell and gene therapy opportunities for patients by advancing access to knowledge and...

Veristat Launches A Flexible Virtual Clinical Trial Solution

Veristat Enhances Patient-Centricity Offering by Delivering Clinical Trials Directly to Patients

...

Veristat Helps Antibe Therapeutics Complete Their Phase IIB Study During COVID-19

In early 2019, Veristat helped Antibe Therapeutics, a biotech company with a drug platform of...

Veristat Strengthens Its European Presence with the Acquisition of TCTC

Increasing Its Footprint and Expanding Therapeutic Expertise to Guide Sponsors Throughout the...

Veristat Advances Game-Changing Pain and Inflammation Therapy

Veristat continues to support Antibe Therapeutics, a biotech company with a drug platform of...

Veristat Supports 12% of all FDA NME Approvals in 2018, a Record-Setting Year for FDA Approvals

Veristat Celebrates Its Support of over 75 Global Regulatory Submissions Since Its Founding

Veristat Supports Antibe Therapeutics for Pain and Inflammation Study

Upon receiving approval from Health Canada, Antibe Therapeutics selected Veristat to immediately...

Veristat Partners with TRI For Risk-Based Monitoring Technology

Veristat Partners with TRI to Provide Centralized and Risk-Based Monitoring Technology to Their...